LITTLETON, Colo., Jan. 04, 2023 (GLOBE NEWSWIRE) -- Vivos Therapeutics, Inc. (“Vivos” or the “Company'') (NASDAQ: VVOS), a medical technology company focused on developing innovative treatments for ...
(RTTNews) - Vivos Therapeutics, Inc. (VVOS) announced a brand new clearance from the FDA for its DNA appliance. The company said the FDA 510(k) clearance as a Class II device gives rise to a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback